secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2022-03-31T23:59:59+00:00
Accession:  0001493152-22-008268
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow Health announces board resignation of Kammer and appointment of Sternberg and Makary
--------------------------------------------------------------------------------

- Dr. Robert J. Kammer resigned from the board effective March 31, 2022; no disagreements cited.
- Board retained Kammer as a special advisor through end of 2022.
- Board expanded to six members; appointed Perry J. Sternberg and Dr. Marty Makary as independent directors.
- Sternberg is CEO of Corium, Inc.; Makary is chief of islet transplant surgery at Johns Hopkins Hospital.
- Sternberg and Makary will receive the Company's standard director compensation package as described in prior proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/0001493152-22-008268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222008268/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-008268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer